v3.23.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Jan. 31, 2023
Jan. 31, 2022
Jan. 31, 2021
Operating activities:      
Net loss $ (176,146) $ (118,161) $ (27,292)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:      
Depreciation and amortization 25,304 21,302 15,908
Non-cash stock-based compensation expense 58,775 36,144 13,489
Amortization of deferred financing costs and debt discount 310 288 389
Cost of Phreesia hardware purchased by customers 1,598 672 762
Deferred contract acquisition costs amortization 1,696 2,211 2,025
Non-cash operating lease expense 1,768 1,004 1,766
Change in fair value of contingent consideration liabilities 0 258 0
Deferred tax asset 434 143 (65)
Changes in operating assets and liabilities, net of acquisitions:      
Accounts receivable (11,132) (10,216) (6,619)
Prepaid expenses and other assets 250 (7,192) (1,600)
Deferred contract acquisition costs (427) (3,349) (1,652)
Accounts payable 4,774 2,881 (3,821)
Accrued expenses and other liabilities 2,720 (2,983) 6,004
Lease liability (1,302) (1,060) (1,786)
Deferred revenue 1,255 3,348 5,382
Net cash (used in) provided by operating activities (90,123) (74,710) 2,890
Investing activities:      
Acquisitions, net of cash acquired 0 (34,423) (6,510)
Capitalized internal-use software (21,471) (12,385) (7,334)
Purchases of property and equipment (4,732) (18,420) (11,241)
Net cash used in investing activities (26,203) (65,228) (25,085)
Financing activities:      
Proceeds from issuance of common stock in equity offerings, net of underwriters' discounts and commissions 0 245,813 174,800
Proceeds from issuance of common stock upon exercise of stock options 1,603 4,889 4,385
Treasury stock to satisfy tax withholdings on stock compensation awards (19,383) (8,995) (4,965)
Payment of offering costs 0 0 (290)
Proceeds from employee stock purchase plan 3,321 1,979 0
Insurance financing agreement 0 0 2,009
Finance lease payments (5,731) (4,267) (2,630)
Principal payments on financing agreements (216) (1,039) (1,691)
Debt issuance costs and facility fees (397) (125) (294)
Financing payments of acquisition-related liabilities 0 (3,286) 0
Payments of revolving line of credit 0 0 (20,663)
Net cash (used in) provided by financing activities (20,803) 234,969 150,661
Net (decrease) increase in cash and cash equivalents (137,129) 95,031 128,466
Cash and cash equivalents—beginning of year 313,812 218,781 90,315
Cash and cash equivalents—end of year 176,683 313,812 218,781
Supplemental information of non-cash investing and financing activities:      
Right-of-use assets recorded in exchange for operating lease liabilities 0 81 4,359
Property and equipment acquisitions through finance leases 526 7,394 8,885
Capitalized software acquired through vendor financing 0 0 174
Purchase of property and equipment and capitalized software included in accounts payable and accrued liabilities 2,345 1,124 3,359
Cashless transfer of term loan and related accrued fees into increase in debt balance 0 0 20,257
Cashless transfer of lender fees through increase in debt balance 0 0 406
Receivables for cash in-transit on stock option exercises 97 169 915
Cashless exercise of common stock warrants 0 0 3,060
Capitalized stock based compensation 1,372 489 0
Issuance of stock to settle liabilities for stock-based compensation 12,284 0 0
Cash paid for:      
Interest 763 802 1,465
Income taxes $ 39 $ 49 $ 64